Search
for

    Sort by

    Research 601–630 of 1000+

    1. Non-competitive androgen receptor inhibition in vitro and in vivo Yearbook of Endocrinology · 2010
    2. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    3. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    4. NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS The Journal of Urology · 2009
    5. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    6. The influence of secoisolariciresinol diglusoside on non-emasculated rat in BPH Journal of Jilin Medical College · 2009
    7. Association between PSA and leptin, adiponectin, HbA1c, or C-peptide among African-American and Caucasian men Cancer Epidemiology and Prevention Biomarkers · 2007
    8. 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 생약학회지 · 2007
    9. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    10. Effect of Low-Dose Finasteride on Serum PSA Concentrations Journal watch · 2007
    11. UP-03.20 Urology · 2006
    12. UP-02.28 Urology · 2006
    13. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    14. Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia? Mayo Clinic Proceedings · 2006
    15. Editorial comment 1 Urology · 2004
    16. Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation Anticancer Research · 2004
    17. PCPT Results Could Affect Trial on Testosterone Replacement Oncology Times · 2003
    18. Australian Hair and Wool Research Society Cutaneous Biology and Endocrinology Workshop Experimental Dermatology · 2003
    19. Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo European Urology Supplements · 2003
    20. Androstenedione Strength and Conditioning Journal · 1999
    21. 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione Acta Crystallographica Section C-crystal Structure Communications · 1998
    22. 187 Protective Effect of DA-9401 on Acute use of Finasteride on Sprague–Dawley Rats The Journal of Sexual Medicine · 2018
    23. PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL The Journal of Urology · 2023
    24. Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors Current Enzyme Inhibition · 2022
    25. How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss Skin appendage disorders · 2022
    26. Androgenetic Alopecia From A to Z Springer eBooks · 2022
    27. Modulation der Hitzesensitivität im Prostatakarzinom in vitro: Der Einfluss der Androgenachse 2022
    28. A Retrospective Study of Semen Quality in Young Infertile Men with Androgenetic Alopecia after Discontinuation of Finasteride 日本薬理学会年会要旨集 = · 2018
    29. One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital Indian journal of health sciences and biomedical research KLEU · 2017
    30. Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint Hair transplant forum international · 2016